PT2731616E - Método para a prevenção e tratamento da sépsis - Google Patents

Método para a prevenção e tratamento da sépsis Download PDF

Info

Publication number
PT2731616E
PT2731616E PT127352961T PT12735296T PT2731616E PT 2731616 E PT2731616 E PT 2731616E PT 127352961 T PT127352961 T PT 127352961T PT 12735296 T PT12735296 T PT 12735296T PT 2731616 E PT2731616 E PT 2731616E
Authority
PT
Portugal
Prior art keywords
sepsis
prevention
treatment
Prior art date
Application number
PT127352961T
Other languages
English (en)
Inventor
Gerardus Anna Franciscus Nicolaes
Christiaan Peter Maria Reutelingsperger
Hendrik Coenraad Hemker
Original Assignee
Academisch Ziekenhuis Maastricht
Univ Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Maastricht, Univ Maastricht filed Critical Academisch Ziekenhuis Maastricht
Publication of PT2731616E publication Critical patent/PT2731616E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT127352961T 2011-07-14 2012-07-12 Método para a prevenção e tratamento da sépsis PT2731616E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11174070A EP2545924A1 (en) 2011-07-14 2011-07-14 Method for the prevention and treatment of sepsis.

Publications (1)

Publication Number Publication Date
PT2731616E true PT2731616E (pt) 2016-01-07

Family

ID=44654609

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127352961T PT2731616E (pt) 2011-07-14 2012-07-12 Método para a prevenção e tratamento da sépsis

Country Status (16)

Country Link
US (1) US9155756B2 (pt)
EP (2) EP2545924A1 (pt)
AU (1) AU2012282505B2 (pt)
CA (1) CA2842060C (pt)
CY (1) CY1117438T1 (pt)
DK (1) DK2731616T3 (pt)
ES (1) ES2555285T3 (pt)
HK (1) HK1197583A1 (pt)
HR (1) HRP20151322T1 (pt)
HU (1) HUE028258T2 (pt)
PL (1) PL2731616T3 (pt)
PT (1) PT2731616E (pt)
RS (1) RS54437B1 (pt)
SI (1) SI2731616T1 (pt)
SM (1) SMT201500310B (pt)
WO (1) WO2013007771A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545924A1 (en) 2011-07-14 2013-01-16 Universiteit Maastricht Method for the prevention and treatment of sepsis.
CN105555800A (zh) * 2013-08-07 2016-05-04 罗切斯特大学 诊断败血症或败血症风险的方法
US10261084B1 (en) 2014-02-19 2019-04-16 Stc.Unm Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
EP3307279B1 (en) * 2015-06-11 2019-12-04 Universiteit Maastricht Method for preventing transplant failure in a host.
US20200118687A1 (en) * 2017-06-12 2020-04-16 Koninklijke Philips N.V. Risk assessment of disseminated intravascular coagulation
WO2024003418A1 (en) * 2022-07-01 2024-01-04 Universiteit Maastricht Improved downregulation of histone cytotoxicity by complex of negatively charged polysaccharide and protease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527785A (en) * 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
US20060229276A1 (en) * 2004-07-28 2006-10-12 Magnus Hook Use of glycosoaminoglycans for the prevention and treatment of sepsis
EP2545924A1 (en) 2011-07-14 2013-01-16 Universiteit Maastricht Method for the prevention and treatment of sepsis.

Also Published As

Publication number Publication date
DK2731616T3 (en) 2015-12-14
EP2731616B1 (en) 2015-09-09
HRP20151322T1 (hr) 2016-01-01
AU2012282505A1 (en) 2014-01-23
ES2555285T3 (es) 2015-12-30
CA2842060A1 (en) 2013-01-17
CY1117438T1 (el) 2017-04-26
SMT201500310B (it) 2016-01-08
PL2731616T3 (pl) 2016-03-31
EP2731616A1 (en) 2014-05-21
HK1197583A1 (zh) 2015-01-30
RS54437B1 (en) 2016-06-30
AU2012282505B2 (en) 2017-04-13
US20140162978A1 (en) 2014-06-12
HUE028258T2 (en) 2016-12-28
WO2013007771A1 (en) 2013-01-17
SI2731616T1 (sl) 2016-02-29
EP2545924A1 (en) 2013-01-16
CA2842060C (en) 2019-08-27
US9155756B2 (en) 2015-10-13

Similar Documents

Publication Publication Date Title
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
EP2747636A4 (en) SYSTEM AND METHOD FOR TREATING SILENTNESS
EP2773754A4 (en) Methods of Treatment
GB201110095D0 (en) Method of treatment
HK1201439A1 (en) Method of treating or reducing efp efp
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
GB201217296D0 (en) Method of treatment and/or prevention
EP2758780A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
HK1197583A1 (zh) 預防和治療敗血症的方法
HK1196289A1 (zh) 用於敗血症的治療和/或改善的藥物
GB201003920D0 (en) Method of treatment
GB201207599D0 (en) Transistor and the method of manufacture
RS57395B1 (sr) Postupak za tretman čelika
EP2745838A4 (en) PROPHYLACTIC AGENT AND / OR THERAPEUTIC AGENT FOR SEPTICEMIA
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
PL2744601T3 (pl) Sposób i instalacja do obróbki przedmiotów
RS59382B1 (sr) Jedinjenja za profilaksu i tretman adhezionog procesa
HK1202260A1 (en) Agent for preventing and or treating veisalgia
EP2585103A4 (en) METHOD OF TREATMENT
EP2791324A4 (en) PROCESSING METHOD
GB201107553D0 (en) Composition and methods for the treatment of neuroendocrine and pitutitary tumoars
PT2716684T (pt) Compostos para a profilaxia e tratamento do processo de adesão
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment